Medicines Australia welcomes ALP R&D investment pledge

Medicines Australia

8 May 2019 - Medicines Australia welcomes today’s announcement from the Australian Labor Party to reform the Research and Development Tax Incentive if elected on 18 May.

Medicines Australia CEO Ms Liz de Somer said: “A collaboration premium to foster stronger links between industry and researchers is a positive step toward strengthening Australia’s medical and pharmaceutical research capacity.

“As an industry, we invest approximately $1 billion in collaborative partnerships, many of which are with research institutes and universities,” she said.

Read Medicines Australia press release

Michael Wonder

Posted by:

Michael Wonder